New York State Common Retirement Fund
AUPH icon

New York State Common Retirement Fund’s Aurinia Pharmaceuticals AUPH Stock Holding History

New York State Common Retirement Fund’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$741K Buy
43,642
+6,000
+16% +$95.8K ﹤0.01% 1850
2026
Q1 		$558K Hold
37,642
– – ﹤0.01% 1869
2025
Q4 		$600K Buy
37,642
+6,400
+20% +$90.7K ﹤0.01% 1896
2025
Q3 		$345K Hold
31,242
– – ﹤0.01% 2075
2025
Q2 		$265K Hold
31,242
– – ﹤0.01% 2136
2025
Q1 		$251K Hold
31,242
– – ﹤0.01% 2141
2024
Q4 		$281K Hold
31,242
– – ﹤0.01% 2154
2024
Q3 		$229K Sell
31,242
-14,300
-31% -$88.7K ﹤0.01% 2228
2024
Q2 		$260K Buy
45,542
+16
+0% +$84 ﹤0.01% 2313
2024
Q1 		$228K Sell
45,526
-3,196
-7% -$21.7K ﹤0.01% 2373
2023
Q4 		$438K Sell
48,722
-5,547
-10% -$45.7K ﹤0.01% 2148
2023
Q3 		$422K Buy
54,269
+8,806
+19% +$86.1K ﹤0.01% 2128
2023
Q2 		$440K Sell
45,463
-25,802
-36% -$268K ﹤0.01% 2144
2023
Q1 		$781K Sell
71,265
-22,933
-24% -$202K ﹤0.01% 1953
2022
Q4 		$407K Sell
94,198
-2
-0% -$12 ﹤0.01% 2417
2022
Q3 		$708K Buy
94,200
+1,200
+1% +$10.4K ﹤0.01% 2161
2022
Q2 		$935K Buy
+93,000
New +$1.04M ﹤0.01% 2050
2017
Q3 		– Sell
-27,234
Closed -$167K – 3101
2017
Q2 		$167K Sell
27,234
-1
-0% -$7 ﹤0.01% 2927
2017
Q1 		$200K Buy
+27,235
New +$126K ﹤0.01% 2771

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New York State Common Retirement Fund's AUPH Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Aurinia Pharmaceuticals (AUPH) stake by 16% in Q2 2026, buying an estimated $95.8K and bringing the position to 43,642 shares worth $741K. The position accounts for ﹤0.01% of the portfolio, ranked #1850.

New York State Common Retirement Fund first reported a position in AUPH in Q1 2017 and has held it in 19 quarters since. The position peaked at $935K in Q2 2022. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • New York State Common Retirement Fund held 43,642 shares of Aurinia Pharmaceuticals worth $741K as of Q2 2026.
  • New York State Common Retirement Fund bought 6,000 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $95.8K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1850 holding.
  • New York State Common Retirement Fund first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 19 quarters since.
  • New York State Common Retirement Fund's Aurinia Pharmaceuticals position peaked at $935K in Q2 2022.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.